Welcome. If you're a registered user, please log-in. If not, please sign-up.

Industry Updates
FierceBiotech >profile  FierceBiotech will be taking off for Good Friday tomorrow, so our next daily newsletter will arrive on Monday. Have a great holiday weekend! 2 hours ago. · reply · retweet · favorite
FierceBiotech >profile  Vital Therapies banks $54M in a downsized IPO retry -- http://t.co/139db9MNE1 by @DamianFierce 3 hours ago. · reply · retweet · favorite
FierceBiotech >profile  Pfizer, AstraZeneca back a new strategy for #cancer drug R&D -- $PFE $AZN http://t.co/Q7CW0C0mLZ by @JohnCFierce 4 hours ago. · reply · retweet · favorite
FierceBiotech >profile  Which therapies top Thomson Reuters' list of new drugs to watch this year? -- http://t.co/8RR95FPoDV by @JohnCFierce 5 hours ago. · reply · retweet · favorite
FierceBiotech >profile  Biotech upstart grabs $18M to study a new drug to protect pregnancies -- http://t.co/QqPZJaX9sb by @JohnCFierce 5 hours ago. · reply · retweet · favorite
FierceBiotech >profile  GlaxoSmithKline and Galapagos succeed in #psoriasis after two setbacks. http://t.co/w8BjiQFBGx by @DamianFierce $GSK 5 hours ago. · reply · retweet · favorite
FierceBiotech >profile  RT @FiercePharma: Our newest special report is live! Top 10 M&A deals of 2013: http://t.co/vG7ZWXcsXj by @EricPFierce and @CarlyHFierce #ph 6 hours ago. · reply · retweet · favorite
FierceBiotech >profile  AMRI plans to shutter an R&D shop to save cash - FierceCRO: http://t.co/1dP1EfF45D by @DamianFierce $AMRI 7 hours ago. · reply · retweet · favorite
FierceBiotech >profile  RT @VarunSaxena2: Alnylam COO on Novartis RNAi pullout: Big Pharma has 'never been able to innovate' - FierceDrugDelivery http://t.co/GASvt… yesterday. · reply · retweet · favorite
FierceBiotech >profile  Alnylam COO on Novartis RNAi pullout: Big Pharma has 'never been able to innovate' -- $ALNY $NVS http://t.co/kSLTZScQXw yesterday. · reply · retweet · favorite
FierceBiotech >profile  Baxter's latest bleeding drug hits the mark in PhIII -- $BAX http://t.co/CnxStCp0Vl yesterday. · reply · retweet · favorite
FierceBiotech >profile  Have the biotech bears run out of steam? -- http://t.co/B4fYkjS8lg yesterday. · reply · retweet · favorite
FierceBiotech >profile  Column Group nears goal line for $250M biotech venture fund -- http://t.co/KrJYJZQCfJ yesterday. · reply · retweet · favorite
FierceBiotech >profile  BioAlliance and Topotarget plan to merge, pooling their #cancer pipelines -- http://t.co/9eoJuRmnYO by @DamianFierce yesterday. · reply · retweet · favorite
FierceBiotech >profile  VCs gamble $96M on rare disease drug, biosimilar play and new drug for AMD -- http://t.co/UHOVhWQMHH yesterday. · reply · retweet · favorite
..
Mark your diary for 2015
Mark your diary for BioProcess International European Summit 2015
Exclusive interview
Exclusive interview
Who will you meet?

 Who will you meet at Bpi ?

Speaker interviews

Speaker interviews

..
PartneringONE is now live!

partneringONE is the leading conference networking solution, turning any conference into a world-class partnering event. Log in today.

New for 2014: partneringONE®

Build New, Productive Contacts with Industry's Leading Partnering Platform

50+ Scientifc Posters

Showcasing the Latest Scientific Data from Industry and Academia. Deadline Friday 28 March 2013

 

SPONSORED BY: CPI

Exhibition Sold out in 2013!

Raise your profile via product tutorials, BPI Live Labs, exhibition space, technology presentations...

Connecting innovations in upstream, downstream, analytics and formulation to accelerate process development, improve product quality and prepare for increasingly diverse pipelines

5 Conference Streams; 1 Price

BPI Europe Agenda

 


Follow our Biopharm Blog

What's New for 2014

  • 10 New Sessions on Continuous processing; platform development for novel products; Media supply and quality control,biomanufacturing in China, ADCs and Bioconjugates; HTPD, continuous process verification, host cell proteins, closed systems,protein aggregation and SVPs…plus many more.
  • partneringONE software as used at BioEurope, BPI Live Labs, Take-Home Message Centre , “Off the Record” Discussion Panels on China, E&L and Novel Format manufacturing;  5 Discussion Panels on continuous processing, innovations in DSP, ADCs, developability and Biosimilars
  • 40+ Posters and 2 New Streams
    Peer-Reviewed Poster Session, plus two new streams on 
    HTPD for Process Improvement andNovel Platforms for Novel Formats
  • 5 New Workshops on: Risk-Based Project Management, ADC Process Development, Biosimilars CMC, Biophysical Methods Developability and Developability strategies, plus Exclusive site Visit to Lonza, Prague

BioProcess Awards

2x1

Special discounts

LinkedIN

Join BioProcessing Professionals Europe and network with the most senior members of the industry

Follow BPIEurope for latest industry news

Contact james.miguel@informa.com for more info

Sponsors
Sponsors
Sponsors
Sponsors
Sponsors
Sponsors
Sponsors
Sponsors
Featured Exhibitors
Sponsors
Sponsors
Sponsors
Sponsors
Featured Exhibitors
Sponsors
Corporate Sponsors
Sponsors
Sponsors
Associate Sponsors
Featured Exhibitors
Sponsors
Corporate Sponsors
Sponsors
Sponsors
Sponsors
Sponsors
Sponsors
Sponsors
Sponsors
..

Corporate Sponsors

..
..
..
..

Associate Sponsors

..
..
..
..

Partnering Sponsor

..
..
..
..

Featured Exhibitors

..
..
..
..

Founding Publication

..
..
..
..

With thanks to our Media Partners

..
..

Training and Development

..
..
..